Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brownstein

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Genomics|June 22, 1999
Cloning, mapping, and expression of two novel actin genes, actin-like-7A (ACTL7A) and actin-like-7B (ACTL7B), from the familial dysautonomia candidate region on 9q31B P Chadwick, J Mull, L A Helbling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset diseaseJ Schleutker, M Matikainen, J Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
American Journal of Human Genetics|February 17, 2001
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomiaS A Slaugenhaupt, A Blumenfeld, S P Gill, et al.
Molecular Cancer Therapeutics|February 14, 2018
Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue SarcomaJeremy M Brownstein, Amy J Wisdom, Katherine D Castle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid TumorsKyriakos P Papadopoulos, Robin Kate Kelley, Anthony W Tolcher, et al.
Nature Genetics|January 19, 2002
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1J Carpten, N Nupponen, S Isaacs, et al.
Nature Genetics|October 15, 1998
Evidence for a prostate cancer susceptibility locus on the X chromosomeJ Xu, D Meyers, D Freije, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Genomics|June 22, 1999
Cloning, mapping, and expression of two novel actin genes, actin-like-7A (ACTL7A) and actin-like-7B (ACTL7B), from the familial dysautonomia candidate region on 9q31B P Chadwick, J Mull, L A Helbling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset diseaseJ Schleutker, M Matikainen, J Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
American Journal of Human Genetics|February 17, 2001
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomiaS A Slaugenhaupt, A Blumenfeld, S P Gill, et al.
Molecular Cancer Therapeutics|February 14, 2018
Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue SarcomaJeremy M Brownstein, Amy J Wisdom, Katherine D Castle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid TumorsKyriakos P Papadopoulos, Robin Kate Kelley, Anthony W Tolcher, et al.
Nature Genetics|January 19, 2002
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1J Carpten, N Nupponen, S Isaacs, et al.
Nature Genetics|October 15, 1998
Evidence for a prostate cancer susceptibility locus on the X chromosomeJ Xu, D Meyers, D Freije, et al.
Pageof 5